Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG

BAY 94-9027 (Jivi) is a site-specifically PEGylated human B-domain-deleted (BDD) recombinant factor VIII (FVIII), with a 60 kDa branched PEG molecule attached. The nonclinical safety of BAY 94-9027 was evaluated in a toxicology program that included 2 weeks intravenous (IV) toxicity studies in rats...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivens, Inge A., Banczyk, David, Gutberlet, Katrin, Jackman, Shawna, Vauléon, Stéphanie, Frisk, Anna-Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696742/
https://www.ncbi.nlm.nih.gov/pubmed/31132933
http://dx.doi.org/10.1177/0192623319852300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696742/
https://www.ncbi.nlm.nih.gov/pubmed/31132933
http://dx.doi.org/10.1177/0192623319852300

Ejemplares similares